Items where authors include "Towse, A."

Article

Newall, A.T., Beutels, P., Kis, Z. et al. (2 more authors) (2023) Placing a value on increased flexible vaccine manufacturing capacity for future pandemics. Vaccine, 41 (14). pp. 2317-2319. ISSN 0264-410X

Latimer, N. orcid.org/0000-0001-5304-5585, Pollard, D., Towse, A. et al. (5 more authors) (2021) Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi‐stakeholder, international workshop. BMC Health Services Research, 21. 412. ISSN 1472-6963

Latimer, N.R. orcid.org/0000-0001-5304-5585, Towse, A. and Henshall, C. (2021) Not cost-effective at zero price : valuing and paying for combination therapies in cancer. Expert Review of Pharmacoeconomics & Outcomes Research, 21 (3). pp. 331-333. ISSN 1473-7167

Jönsson, B., Hampson, G., Michaels, J. et al. (3 more authors) (2019) Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare. The European Journal of Health Economics, 20 (3). pp. 427-438. ISSN 1618-7598

Phelps, C., Lakdawalla, D., Basu, A. et al. (3 more authors) (2018) Approaches to Aggregation and Decision Making - A Health Economics Approach : An ISPOR Special Task Force Report [5]. Value in Health. 146 - 154. ISSN 1524-4733

Garrison, Louis R., Neumann, P., Willke, R. et al. (10 more authors) (2018) A Health Economics Approach to US Value Assessment Frameworks - Summary and Recommendations of the ISPOR Special Task Force Report [7]. Value in Health. pp. 161-165. ISSN 1524-4733

Danzon, P., Drummond, M.F. orcid.org/0000-0002-6126-0944, Towse, A. et al. (1 more author) (2018) Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach: An ISPOR Special Task Force Report [4]. Value in Health. 140 - 145. ISSN 1524-4733